Vincerx Pharma, Inc.
VINCDelisted Apr 28, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001796129
Vincerx Pharma, Inc. was delisted on Apr 28, 2025; its insiders filed their last Form 4 on Aug 14, 2024; 14 institutions reported holding it in 13F filings for Q1 2025, worth $116.8K in total; no superinvestor held it.
Q2 2021 vs. Q1 2021
How the institutions holding Vincerx Pharma, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 36 | 56 | +20 |
| Shares | 8.86M | 12.1M | +3.25M (+36.7%) |
| Value | $171.0M | $157.3M | −$13.7M (−8.0%) |
New holders (26)
Institutions that held Vincerx Pharma, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
Sold out (6)
Institutions that held Vincerx Pharma, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Logos Global Management LP | 480,000 | $9.26M |
| Perceptive Advisors LLC | 300,000 | $5.79M |
| Verition Fund Management LLC | 50,406 | $973.0K |
| Credit Suisse AG | 26,568 | $513.0K |
| ExodusPoint Capital Management, LP | 17,835 | $344.0K |
| Susquehanna International Group, LLP | 10,869 | $210.0K |